Archer Daniels Q2 Earnings: Will Soft Segment Trends Mar Results?

Archer Daniels Midland (ADM) is forecast to report a Q2 2025 EPS of $0.88, a 14.6% year-over-year decline, on revenues of $21.1 billion, down 5.1% year-over-year. This expected downturn stems largely from persistent headwinds in its Ag Services and Oilseeds segment, including weak crush margins, low oil prices, and policy uncertainties, despite anticipated modest growth in the Nutrition segment. While the Zacks model does not predict an earnings beat and rates ADM a 'Sell,' the stock currently trades at an attractive valuation relative to its industry.

Analysis

Archer Daniels Midland is poised to report a significant year-over-year decline in its second-quarter 2025 results, with consensus estimates pointing to a 14.6% drop in EPS to $0.88 and a 5.1% fall in revenue to $21.1 billion. The primary driver of this anticipated weakness is the Ag Services and Oilseeds segment, which faces severe pressure from weak crush margins, depressed vegetable oil prices due to market oversupply, and policy uncertainty impacting biofuel margins. Management has reinforced this cautious outlook, expecting the segment's results to remain lower year-over-year for the rest of 2025 and noting that Q2 crush margins are trending below Q1. The Carbohydrate Solutions segment is also expected to contract slightly by 0.9% amid softening customer demand. In contrast, the Nutrition segment stands out as a modest bright spot, with revenues forecast to grow 0.8% to $1.9 billion, driven by strategic restructuring and innovation. Despite the bleak operational forecast and a Zacks #4 (Sell) rating, ADM stock presents a valuation conflict; it trades at a forward P/E of 12.29X, a discount to both its five-year high and the industry average of 14.77X, and has rallied 13.4% in the past three months, outpacing its peers.

Key Decisions for Investors

• Given the explicit management warnings and consensus for a double-digit earnings decline, investors should approach the upcoming earnings report with caution, focusing on whether the Ag Services and Oilseeds segment's performance is worse than already priced in.
• The conflict between the stock's attractive valuation at a 12.29X forward P/E and the deteriorating fundamental outlook warrants careful consideration; value-focused investors may see an opportunity, but must weigh it against the significant operational risks and a Zacks #4 (Sell) rating.
• Pay close attention to any revisions in management's guidance for the second half of 2025, particularly regarding crush margin recovery and demand in the Carbohydrate Solutions segment, as these will be critical indicators for a potential turnaround.
• The performance of the Nutrition division, though a small part of the business, should be monitored as a key proof point for the company's long-term strategic initiatives and its ability to generate growth outside of its challenged core segments.